NorthView Acquisition (NVACR) Competitors $0.05 0.00 (0.00%) (As of 09/18/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends NVACR vs. DRTSW, ANZUW, BBLGW, BRSHW, GMVDW, HSCSW, BEATW, LUCYW, IINNW, and NXGLWShould you be buying NorthView Acquisition stock or one of its competitors? The main competitors of NorthView Acquisition include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), Innovative Eyewear (LUCYW), Inspira Technologies Oxy B.H.N. (IINNW), and NEXGEL (NXGLW). These companies are all part of the "medical equipment" industry. NorthView Acquisition vs. Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care G Medical Innovations Heart Test Laboratories HeartBeam Innovative Eyewear Inspira Technologies Oxy B.H.N. NEXGEL NorthView Acquisition (NASDAQ:NVACR) and Alpha Tau Medical (NASDAQ:DRTSW) are both manufacturing companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk, community ranking and dividends. Do analysts recommend NVACR or DRTSW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NorthView Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAlpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has preferable earnings & valuation, NVACR or DRTSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNorthView AcquisitionN/AN/AN/AN/AN/AAlpha Tau MedicalN/AN/AN/AN/AN/A Does the media prefer NVACR or DRTSW? In the previous week, Alpha Tau Medical's average media sentiment score of 0.88 beat NorthView Acquisition's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Overall Sentiment NorthView Acquisition Neutral Alpha Tau Medical Positive Does the MarketBeat Community favor NVACR or DRTSW? NorthView Acquisition and Alpha Tau Medical both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformNorthView AcquisitionN/AN/AAlpha Tau MedicalN/AN/A Is NVACR or DRTSW more profitable? Company Net Margins Return on Equity Return on Assets NorthView AcquisitionN/A N/A N/A Alpha Tau Medical N/A N/A N/A SummaryAlpha Tau Medical beats NorthView Acquisition on 1 of the 1 factors compared between the two stocks. Ad Weiss RatingsWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” Get NorthView Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for NVACR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVACR vs. The Competition Export to ExcelMetricNorthView AcquisitionSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/A$3.73M$2.08B$8.46BDividend YieldN/AN/A2.63%4.07%P/E RatioN/A10.5827.5818.79Price / SalesN/A459.61638.6271.78Price / CashN/A8.3553.4531.48Price / BookN/A0.692.534.56Net IncomeN/AN/A$170.80M$224.92M7 Day PerformanceN/A3.33%1.84%5.48%1 Month PerformanceN/A-8.61%1.89%5.93%1 Year PerformanceN/A3.25%10.58%13.82% NorthView Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRTSWAlpha Tau Medical0 of 5 stars0.00 / 5 stars$0.18-5.3%N/A-35.1%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp I0 of 5 stars0.00 / 5 stars$0.09-1.1%N/A-29.4%$0.00N/A0.002Gap UpBBLGWBone Biologics0 of 5 stars0.00 / 5 stars$60.50-13.6%N/AN/A$0.00N/A0.002Positive NewsBRSHWBruush Oral Care0 of 5 stars0.00 / 5 stars$0.01-1.8%N/AN/A$0.00$2.92M0.0011Gap UpGMVDWG Medical Innovations0 of 5 stars0.00 / 5 stars$6.90+26.4%N/AN/A$0.00$4.42M0.0072Gap UpHSCSWHeart Test Laboratories0 of 5 stars0.00 / 5 stars$0.04-6.1%N/AN/A$0.00$18,600.000.0010Gap DownBEATWHeartBeam0 of 5 stars0.00 / 5 stars$0.55-8.2%N/A+95.9%$0.00N/A0.005Gap DownLUCYWInnovative Eyewear0 of 5 stars0.00 / 5 stars$0.03-49.9%N/A-55.4%$0.00$1.53M0.009News CoverageGap DownIINNWInspira Technologies Oxy B.H.N.0 of 5 stars0.00 / 5 stars$0.29flatN/A+43.2%$0.00N/A0.0020News CoveragePositive NewsNXGLWNEXGEL0 of 5 stars0.00 / 5 stars$0.49+22.5%N/A+30.9%$0.00$5.01M0.0010Positive NewsHigh Trading Volume Related Companies and Tools Related Companies: DRTSW Alternatives ANZUW Alternatives BBLGW Alternatives BRSHW Alternatives GMVDW Alternatives HSCSW Alternatives BEATW Alternatives LUCYW Alternatives IINNW Alternatives NXGLW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NVACR) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NorthView Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NorthView Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.